- Previous Close
3.7400 - Open
3.7600 - Bid 3.7300 x --
- Ask 3.7800 x --
- Day's Range
3.7600 - 3.7600 - 52 Week Range
3.2300 - 5.1200 - Volume
400 - Avg. Volume
7,892 - Market Cap (intraday)
139.954M - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
12.97 - EPS (TTM)
0.2900 - Earnings Date May 15, 2025
- Forward Dividend & Yield 0.10 (2.66%)
- Ex-Dividend Date May 28, 2025
- 1y Target Est
5.70
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts and components; and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, cable filling compounds, and process oil, as well as construction, cosmetic, and pharmaceutical specialties. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. H&R GmbH & Co. KGaA was founded in 1919 and is headquartered in Salzbergen, Germany.
www.hur.com1,705
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2HRA.DE
View More
Performance Overview: 2HRA.DE
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2HRA.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2HRA.DE
View MoreValuation Measures
Market Cap
139.95M
Enterprise Value
270.55M
Trailing P/E
12.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
0.33
Enterprise Value/Revenue
0.20
Enterprise Value/EBITDA
2.95
Financial Highlights
Profitability and Income Statement
Profit Margin
0.79%
Return on Assets (ttm)
2.05%
Return on Equity (ttm)
2.78%
Revenue (ttm)
1.35B
Net Income Avi to Common (ttm)
10.62M
Diluted EPS (ttm)
0.2900
Balance Sheet and Cash Flow
Total Cash (mrq)
62.53M
Total Debt/Equity (mrq)
53.69%
Levered Free Cash Flow (ttm)
8.45M